A Randomized, Phase II Study of Apalutamide plus/minus Stereotactic Body Radiotherapy (SBRT) in Castration-Resistant Prostate Cancer Patients With Oligometastatic Disease on PSMA-PET Imaging
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Jan 2019
At a glance
- Drugs Apalutamide (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms PILLAR
- 21 Dec 2018 Planned initiation date changed from 1 Dec 2018 to 1 Mar 2019.
- 19 Oct 2018 Planned initiation date changed from 1 Jul 2018 to 1 Dec 2018.
- 31 Aug 2018 Biomarkers information updated